Compare SLN & PCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SLN | PCB |
|---|---|---|
| Founded | 1994 | 2003 |
| Country | | US |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 318.4M | 324.9M |
| IPO Year | N/A | 2018 |
| Metric | SLN | PCB |
|---|---|---|
| Price | $4.83 | $23.43 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 2 |
| Target Price | ★ $39.67 | $24.50 |
| AVG Volume (30 Days) | ★ 203.2K | 18.9K |
| Earning Date | 01-01-0001 | 04-30-2026 |
| Dividend Yield | N/A | ★ 3.79% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.94 |
| Revenue | N/A | ★ $2,774,000.00 |
| Revenue This Year | N/A | $13.73 |
| Revenue Next Year | N/A | $9.07 |
| P/E Ratio | ★ N/A | $12.01 |
| Revenue Growth | N/A | ★ 4.68 |
| 52 Week Low | $1.97 | $16.02 |
| 52 Week High | $7.78 | $24.20 |
| Indicator | SLN | PCB |
|---|---|---|
| Relative Strength Index (RSI) | 47.85 | 56.67 |
| Support Level | $4.38 | $22.36 |
| Resistance Level | $4.97 | $23.52 |
| Average True Range (ATR) | 0.40 | 0.63 |
| MACD | 0.06 | -0.02 |
| Stochastic Oscillator | 79.20 | 63.50 |
Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.
PCB Bancorp is a bank holding company, which engages in the provision of consumer and commercial banking services. It provides Personal, Business, and Loan services, which provide banking, lending, and digital, tools, home loans, and others. Also, it offers a broad range of loans, deposits, and other products and services predominantly to small and middle-market businesses and individuals. The company provided it's services in Los Angeles and Orange Counties, California; Bellevue, Washington; and Atlanta, Georgia.